Back

Discussant review: An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial Fibrilation

28 August 2017 (11:46 - 11:51)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 2 Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

17 More presentations in this session

Presentation thumbnail
SPYRAL HTN OFF-MED Study
Professor M. Boehm (Homburg, DE)
Slides Video
Presentation thumbnail
Discussant review: SPYRAL HTN OFF-MED Study
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Panel discussion.
Presentation thumbnail
Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Professor M. Ezekowitz (Philadelphia, US)
Slides Video
Presentation thumbnail
Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Professor J. Nielsen (Aarhus, DK)
Slides Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Clinical Trials 2

The Event

Event poster

ESC Congress 2017

28 August 2017 11:46 CET
You may be interested in
thumbnail
Congress Presentation
Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial
31 August 2020
thumbnail
Congress Session
Stroke and bleeding risk in atrial fibrillation: walking the tight rope
25 August 2023
thumbnail
Congress Presentation
Discussant review - AFFIRMO
30 August 2026
thumbnail
Congress Presentation
Association between personalized evidence-based anticoagulation therapy and outcomes at 1-year follow-up in patients with atrial fibrillation: an analysis from the Atrial Fibrillation Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources